Results 1 to 10 of about 101,669 (168)
Management of risperidone-induced hyperprolactinemia in children: a case report
European Psychiatry, 2023 Introduction Antipsychotics have shown their interest in several pathologies of children and adolescents. However, in this vulnerable population, they are not exempt from adverse effects.
H. Belhadga, Z. Elmaataoui, H. Kisra
doaj +1 more source
Tyrosinemia type 1 and ADHD like symptoms similarity or comorbidity about a case
European Psychiatry, 2023 Introduction Many metabolic diseases influence brain function and are associated with psychiatric symptoms and neuropsychiatric disorders (including autism-spectrum disorders, ADHD and psychotic disorders).
H. Belhadga, Z. Elmaataoui, H. Kisra
doaj +1 more source
Representations of long-acting antipsychotics in patients at the Arrazi hospital in Salé Morocco
European Psychiatry, 2023 Introduction Since the appearance of long-acting antipsychotics (LAPAs) and given the high frequency of non-adherence to treatment in psychotic disorders, LAPAs have recognized a resurgence of interest in the psychiatric literature.
H. Chebli +4 more
doaj +1 more source
Association between autoimmune diseases and mental disorders in children and adolescents
European Psychiatry, 2023 Introduction Autoimmune diseases play a role in the etiology of a range of psychotic disorders which has attracted increasing interest in recent decades.
Z. Elmaataoui, H. Belhadga, H. Kisra
doaj +1 more source
European Psychiatry, 2023 Introduction Elevated blood levels of homocysteine have been associated with several psychiatric and neurodegenerative disorders such as schizophrenic disorders, Alzheimer’s disease, Parkinson’s disease and depression. The hypothesis is that genetic and
Z. Elmaataoui, H. BELHADGA, H. KISRA
doaj +1 more source
quality of remission in the major depressive disorder
European Psychiatry, 2023 Introduction Depression is second only to cardiovascular disease as a cause of disability and affects 3 to 5% of the general population. The therapist always tries to guarantee a total remission of the symptoms of depression, but partial remission ...
H. Chebli +4 more
doaj +1 more source
European Psychiatry, 2023 Introduction Disruptive Mood Dysregulation Disorder (DMDD) is a new disorder that has been added to the category of mood disorders in the fifth Diagnostic and Statistical Manual of Mental Disorders to distinguish chronic non-periodic irritability from ...
H. Belhadga, Z. Elmaataoui, H. Kisra
doaj +1 more source
European Psychiatry, 2023 Introduction Antipsychotics have shown their interest in several pathologies of the child and the adolescent. However, in this vulnerable population, they are not without adverse effects. Depending on the type of molecule used, classical neuroleptics or
Z. Elmaataoui, H. Belhadga, H. Kisra
doaj +1 more source
depressive disorder and herpes zoster oticus: a case report
European Psychiatry, 2023 Introduction The herpes zoster oticus results from the reactivation of the varicella zoster virus, a DNA virus of the Herpesviridae family with strictly human-to-human contamination, affecting the geniculate ganglion of the facial nerve.
H. Chebli +3 more
doaj +1 more source
Psychiatric disorders in women hospitalized at the arrazi psychiatric hospital
European Psychiatry, 2023 Introduction Women get hospitalized for various serious mental disorders that are gender specific, half of them married with children, the other half single\divorced women stigmatized and marginalized in our society.
H. Berrada +4 more
doaj +1 more source